The Alkaline Phosphatase pipeline drugs market research report outlays comprehensive information on the Alkaline Phosphatase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Alkaline Phosphatase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Genetic Disorders, Genito Urinary System, and Immunology which include the indications Pancreatic Cancer, Gastric Cancer, Hypophosphatasia, Neurofibromatoses Type I (Von Recklinghausen’s Disease), Acute Renal Failure (ARF) (Acute Kidney Injury), and Inflammation. It also reviews key players involved in Alkaline Phosphatase targeted therapeutics development with respective active and dormant or discontinued products.
The Alkaline Phosphatase pipeline targets constitutes close to 15 molecules. Out of which, approximately 14 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, IND/ CTA Filed, and Preclinical stages are 2, 3, 4, 2, and 3 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Alkaline Phosphatase overview
Alkaline phosphatase (ALP) is an enzyme that is found in various tissues throughout the human body. Alkaline phosphatase catalyzes the removal of phosphate groups from various molecules, particularly at an alkaline pH. It is involved in the hydrolysis of phosphate groups from a variety of substrates, including nucleotides, proteins, and alkaloids.
For a complete picture of Alkaline Phosphatase’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.